HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

The company reported revenue of $37.2 million in the first quarter, up 39% year-over-year, but said it has faced challenges ...

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

The week’s remaining deals came from small Asian issuers, led by Chinese supply chain management firm Majestic Ideal Holdings ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S. initial public ...

The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...